search
Back to results

Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in Schizophrenia

Primary Purpose

Auditory Hallucination, Verbal

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Transcranial direct current stimulation (tDCS)
Sponsored by
University of Ottawa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Auditory Hallucination, Verbal focused on measuring Schizophrenia, Transcranial direct current stimulation (tDCS), Schizoaffective disorder, EEG, Brain imaging, Cognition

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Patients - Inclusion Criteria:

  • Primary diagnosis of schizophrenia or schizoaffective disorder
  • Clinically stable (discretion of psychiatrist)
  • Consistent history of AVHs over the course of illness
  • >3 AVHs per week
  • Positive and Negative Syndrome Scale (PANSS) score of >3
  • Primary medications limited to one of the atypical antipsychotics (medications stabilized for 4 weeks prior to enrollment)

Patients - Exclusion Criteria:

  • Experiencing an acute psychotic episode
  • Current drug/alcohol dependence
  • Significant medical illness & mental retardation/learning disability
  • Extra-pyramidal symptoms resulting in disordered movement
  • Abnormal audiometric assessment (thresholds for pure tones >25 dB)
  • History of significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes

Healthy Controls - Inclusion Criteria:

  • In good physical health
  • No history of serious mental health issues

Healthy Controls - Exclusion Criteria:

  • Personal history of psychiatric disorder
  • Family history of schizophrenia in first degree relatives & history of mental health issues in first degree relatives that required extensive treatment or hospitalization
  • Current/history of substance abuse
  • Significant medical illness
  • Extra-pyramidal symptoms resulting in movement disorder
  • Abnormal audiometric assessment (thresholds for pure tones >25 dB)
  • Significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes

Sites / Locations

  • Royal Ottawa Mental Health CentreRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Sham Comparator

Other

No Intervention

Arm Label

Active tDCS

Sham tDCS

Open-label Active tDCS

Healthy Control

Arm Description

Administration of a 2 milliamp (mA) current delivered via two scalp electrodes for 20 minutes (ramp-in + ramp-out periods, 30s total) 2 times per day for 5 consecutive days, >3 hour interval between sessions, for a total of 10 tDCS sessions. tDCS will be administered with a constant current regulator (NeuroConn DC-Stimulator Plus®, Germany) using 2 saline-soaked sponge electrodes applied over the scalp. Using the 10-20 international EEG system for tDCS electrode placement, the anode will be positioned midway between F3 and Fp1 (left DLPFC) and the cathode midway between T3 and P3 (left TPJ).

Administration of 2mA tDCS for 30 seconds followed by 19.5 minutes of no current via two scalp electrodes for 20 min (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.

Subjects who have received sham tDCS will be given the option to subsequently receive 10 sessions of open-label active tDCS (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.

Healthy volunteers will complete the same questionnaires, EEG recording procedures, and neuroimaging scans as the schizophrenia patient group, but will not undergo tDCS.

Outcomes

Primary Outcome Measures

Change in auditory hallucination severity measured by the Psychotic Symptom Rating Scale (PSYRATS)
The PSYRATS is a multidimensional measure of auditory hallucinations, including 11 items rated on five-point (0-4) scales (total score range 0-44). Symptoms are rated over the last week, with higher scores reflecting more severe symptoms. The dimensions assessed are frequency, duration, location, loudness, beliefs about origin, negative content, intensity of negative content, amount of distress, intensity of distress, disruption of life and control.

Secondary Outcome Measures

Change in Voice Power Differential Scale (VPDS) Scores
The Voice Power Differential Scale (VPDS) is a 7-item scale used to measure the perceived power differences between the voice and the voice hearer. Each item is rated on a five-point scale (1-5), with higher scores indicating greater power differential in favour of the voices, with total scores ranging from 7-35.
Change in Beliefs about Voices Questionnaire-Revised (BAVQ-R) Scores
The BAVQ-R is a 35-item questionnaire assessing people's beliefs about auditory hallucinations, and their emotional and behavioural reactions to them. All responses are rated on a 4-point scale: disagree (0); unsure (1); agree slightly (2); agree strongly (3), the measure thus assesses degree of endorsement of items. The scale consists of five subscales: malevolence (score range 0-18), benevolence (0-18), omnipotence (0-18), resistance (0-27), and engagement (0-24).
Change in Voices Acceptance and Action Scale (VAAS) Scores
The VAAS was developed to assess acceptance-based or action-based beliefs in response to auditory verbal hallucinations, in general and specifically to command hallucinations. This 31-item scale is divided into section A (i.e., 12 item stand-alone scale for general auditory hallucinations) and section B, referring specifically to command hallucinations. The participant is asked to rate their opinion from 1 'Strongly Disagree' to 5 'Strongly Agree', with higher scores meaning higher levels of acceptance and perception of acting according to one's valued life directions. Section A scores can range from 12-60, while section B scores can range from 19-95.
Change in Electroencephalography (EEG) - Resting-State Alpha Power
Changes in resting-state EEG power in alpha band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Beta Power
Changes in resting-state EEG power in beta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Delta Power
Changes in resting-state EEG power in delta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Theta Power
Changes in resting-state EEG power in theta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Resting-State Gamma Power
Changes in resting-state EEG power in gamma band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Change in Electroencephalography (EEG) - Mismatch Negativity (MMN)
Change in MMN peak amplitudes and latencies to non-speech (tonal) deviants and speech (syllabic) deviants during the multi-feature optimal MMN paradigm.
Change in Electroencephalography (EEG) - P50
Change in T/C ratio (testing stimulus/conditioning stimulus) during paired click test. Change in T/C difference (testing stimulus - conditioning stimulus) during paired click test
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Resting-State
Changes in resting-state activity and connectivity within and between the auditory cortex and select regions of the default-mode network.
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Mismatch Negativity (tonal)
Changes in task-related activity and connectivity within and between the auditory cortex and select regions of the default-mode network .
Change in Brain Magnetic Resonance Spectroscopy (MRS)
Changes in glutamate/glutamine (Glu/Gln) concentrations in the auditory cortex.
Change in Cambridge Neuropsychological Test Automated Battery (CANTAB) Schizophrenia Battery
Changes in cognitive functioning abilities in core domains often affected in psychosis.
Change in Social Cognition - Social Attribution Task
Changes in social cognition/social inference abilities measured by a computerized social attribution task.

Full Information

First Posted
April 15, 2019
Last Updated
January 6, 2020
Sponsor
University of Ottawa
Collaborators
The Royal Ottawa Mental Health Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT04222582
Brief Title
Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in Schizophrenia
Official Title
The Neural, Behavioural, and Cognitive Outcomes of Transcranial Direct Current Stimulation (tDCS) for Persistent Auditory Verbal Hallucinations in Schizophrenia
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
January 2021 (Anticipated)
Study Completion Date
January 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Ottawa
Collaborators
The Royal Ottawa Mental Health Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Many individuals with schizophrenia struggle with auditory verbal hallucinations (AVHs). In some cases, these AVHs can be resistant to medication treatment. Previous research has found that transcranial direct current stimulation (tDCS) can be helpful in treating symptoms in individuals with other psychiatric disorders, such as depression. This study will assess if tDCS is effective in treating AVHs in individuals with schizophrenia. tDCS is a non-invasive form of brain stimulation which uses a weak current to temporarily excite or inhibit underlying cortical regions with small electrodes placed on the scalp. tDCS has been found to improve mental processes, including attention and memory function. In addition to examining the effect of tDCS on AVHs, this study will assess the effects of tDCS on mood as well as brain electrical activity with electroencephalogram (EEG) recordings. As an additional component, participants will be invited to participate in neuroimaging. Using magnetic resonance imaging (MRI), brain activity and structure will be examined before and after tDCS. tDCS will be administered twice daily for 5 consecutive days for a total of 10 sessions. These study findings will contribute to the understanding of the impact of tDCS on AVHs, and will also increase knowledge of sound and memory/cognitive processing in individuals with schizophrenia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Auditory Hallucination, Verbal
Keywords
Schizophrenia, Transcranial direct current stimulation (tDCS), Schizoaffective disorder, EEG, Brain imaging, Cognition

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active tDCS
Arm Type
Active Comparator
Arm Description
Administration of a 2 milliamp (mA) current delivered via two scalp electrodes for 20 minutes (ramp-in + ramp-out periods, 30s total) 2 times per day for 5 consecutive days, >3 hour interval between sessions, for a total of 10 tDCS sessions. tDCS will be administered with a constant current regulator (NeuroConn DC-Stimulator Plus®, Germany) using 2 saline-soaked sponge electrodes applied over the scalp. Using the 10-20 international EEG system for tDCS electrode placement, the anode will be positioned midway between F3 and Fp1 (left DLPFC) and the cathode midway between T3 and P3 (left TPJ).
Arm Title
Sham tDCS
Arm Type
Sham Comparator
Arm Description
Administration of 2mA tDCS for 30 seconds followed by 19.5 minutes of no current via two scalp electrodes for 20 min (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.
Arm Title
Open-label Active tDCS
Arm Type
Other
Arm Description
Subjects who have received sham tDCS will be given the option to subsequently receive 10 sessions of open-label active tDCS (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.
Arm Title
Healthy Control
Arm Type
No Intervention
Arm Description
Healthy volunteers will complete the same questionnaires, EEG recording procedures, and neuroimaging scans as the schizophrenia patient group, but will not undergo tDCS.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation (tDCS)
Intervention Description
Transcranial direct current stimulation (tDCS) is a non-invasive form of brain stimulation which uses a weak current (2mA direct current) to temporarily excite or inhibit underlying brain regions with small electrodes placed on the scalp.
Primary Outcome Measure Information:
Title
Change in auditory hallucination severity measured by the Psychotic Symptom Rating Scale (PSYRATS)
Description
The PSYRATS is a multidimensional measure of auditory hallucinations, including 11 items rated on five-point (0-4) scales (total score range 0-44). Symptoms are rated over the last week, with higher scores reflecting more severe symptoms. The dimensions assessed are frequency, duration, location, loudness, beliefs about origin, negative content, intensity of negative content, amount of distress, intensity of distress, disruption of life and control.
Time Frame
Baseline, after 2nd tDCS session on days 1, 3, and 5, and follow-up (within a week of completing tDCS)
Secondary Outcome Measure Information:
Title
Change in Voice Power Differential Scale (VPDS) Scores
Description
The Voice Power Differential Scale (VPDS) is a 7-item scale used to measure the perceived power differences between the voice and the voice hearer. Each item is rated on a five-point scale (1-5), with higher scores indicating greater power differential in favour of the voices, with total scores ranging from 7-35.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Beliefs about Voices Questionnaire-Revised (BAVQ-R) Scores
Description
The BAVQ-R is a 35-item questionnaire assessing people's beliefs about auditory hallucinations, and their emotional and behavioural reactions to them. All responses are rated on a 4-point scale: disagree (0); unsure (1); agree slightly (2); agree strongly (3), the measure thus assesses degree of endorsement of items. The scale consists of five subscales: malevolence (score range 0-18), benevolence (0-18), omnipotence (0-18), resistance (0-27), and engagement (0-24).
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Voices Acceptance and Action Scale (VAAS) Scores
Description
The VAAS was developed to assess acceptance-based or action-based beliefs in response to auditory verbal hallucinations, in general and specifically to command hallucinations. This 31-item scale is divided into section A (i.e., 12 item stand-alone scale for general auditory hallucinations) and section B, referring specifically to command hallucinations. The participant is asked to rate their opinion from 1 'Strongly Disagree' to 5 'Strongly Agree', with higher scores meaning higher levels of acceptance and perception of acting according to one's valued life directions. Section A scores can range from 12-60, while section B scores can range from 19-95.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Resting-State Alpha Power
Description
Changes in resting-state EEG power in alpha band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Resting-State Beta Power
Description
Changes in resting-state EEG power in beta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Resting-State Delta Power
Description
Changes in resting-state EEG power in delta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Resting-State Theta Power
Description
Changes in resting-state EEG power in theta band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Resting-State Gamma Power
Description
Changes in resting-state EEG power in gamma band. Resting-state recordings completed in both eyes-closed and eyes-open conditions, 5 minutes each.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - Mismatch Negativity (MMN)
Description
Change in MMN peak amplitudes and latencies to non-speech (tonal) deviants and speech (syllabic) deviants during the multi-feature optimal MMN paradigm.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Electroencephalography (EEG) - P50
Description
Change in T/C ratio (testing stimulus/conditioning stimulus) during paired click test. Change in T/C difference (testing stimulus - conditioning stimulus) during paired click test
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Resting-State
Description
Changes in resting-state activity and connectivity within and between the auditory cortex and select regions of the default-mode network.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Brain Functional Magnetic Resonance Imaging (fMRI) - Mismatch Negativity (tonal)
Description
Changes in task-related activity and connectivity within and between the auditory cortex and select regions of the default-mode network .
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Brain Magnetic Resonance Spectroscopy (MRS)
Description
Changes in glutamate/glutamine (Glu/Gln) concentrations in the auditory cortex.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Cambridge Neuropsychological Test Automated Battery (CANTAB) Schizophrenia Battery
Description
Changes in cognitive functioning abilities in core domains often affected in psychosis.
Time Frame
3 weeks (baseline to follow-up)
Title
Change in Social Cognition - Social Attribution Task
Description
Changes in social cognition/social inference abilities measured by a computerized social attribution task.
Time Frame
3 weeks (baseline to follow-up)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Patients - Inclusion Criteria: Primary diagnosis of schizophrenia or schizoaffective disorder Clinically stable (discretion of psychiatrist) Consistent history of AVHs over the course of illness >3 AVHs per week Positive and Negative Syndrome Scale (PANSS) score of >3 Primary medications limited to one of the atypical antipsychotics (medications stabilized for 4 weeks prior to enrollment) Patients - Exclusion Criteria: Experiencing an acute psychotic episode Current drug/alcohol dependence Significant medical illness & mental retardation/learning disability Extra-pyramidal symptoms resulting in disordered movement Abnormal audiometric assessment (thresholds for pure tones >25 dB) History of significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes Healthy Controls - Inclusion Criteria: In good physical health No history of serious mental health issues Healthy Controls - Exclusion Criteria: Personal history of psychiatric disorder Family history of schizophrenia in first degree relatives & history of mental health issues in first degree relatives that required extensive treatment or hospitalization Current/history of substance abuse Significant medical illness Extra-pyramidal symptoms resulting in movement disorder Abnormal audiometric assessment (thresholds for pure tones >25 dB) Significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bronwen Schryver, B.Sc.
Phone
613 722 6521
Ext
6094
Email
bronwen.schryver@theroyal.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Verner Knott, PhD, C.Psych
Organizational Affiliation
University of Ottawa
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Natalia Jaworska, PhD
Organizational Affiliation
University of Ottawa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal Ottawa Mental Health Centre
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Z7K4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bronwen Schryver, B.Sc.
Phone
800-987-6424
Ext
6094
Email
bronwen.schryver@theroyal.ca
First Name & Middle Initial & Last Name & Degree
Verner Knott, PhD, C.Psych
First Name & Middle Initial & Last Name & Degree
Natalia Jaworska, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in Schizophrenia

We'll reach out to this number within 24 hrs